ZOLL Medical Corporation Secures $37 Million in Funding for Life-Saving Technologies

ZOLL Medical Corporation, a pivotal player in the emergency care sector and a proud member of the Asahi Kasei Group, has successfully raised $37 million in its latest funding round. This influx of capital is set to fortify ZOLL’s mission of advancing life-saving technologies and enhancing the efficiency of clinical operations. Renowned for its innovative products that cover a spectrum of critical areas—from defibrillation and monitoring to CPR feedback and therapeutic temperature management—ZOLL is dedicated to equipping clinicians, EMS professionals, and lay rescuers with the tools they need to provide effective treatment for victims in need of resuscitation and critical care. The newly acquired funds will bolster ZOLL's research and development initiatives, enabling the company to accelerate the creation of cutting-edge medical devices and software solutions that significantly improve patient outcomes. Additionally, this funding will support the expansion of ZOLL's market presence, allowing them to reach a broader audience and ultimately save more lives worldwide. As a member of the Asahi Kasei Group, which encompasses a wide array of healthcare operations and serves more than 100 countries, ZOLL is well-positioned to leverage its expertise and innovate at the intersection of technology and healthcare. This funding marks another milestone in ZOLL's journey, underscoring its commitment to providing robust, reliable solutions in emergency care, and reflecting the urgent need for advancement in this critical field. For more information about ZOLL Medical Corporation and its transformative technologies, please visit www.asahi-kasei.co.jp/asahi/en/.